Patents by Inventor Laura Sen

Laura Sen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150374860
    Abstract: The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.
    Type: Application
    Filed: May 4, 2015
    Publication date: December 31, 2015
    Inventors: Alison O'Neill, Douglas B. Jacoby, Abdellah Sentissi, Kamala Kesavan, E. Michael Egan, Laura Sen
  • Patent number: 9023595
    Abstract: The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: May 5, 2015
    Assignee: Morphotek, Inc.
    Inventors: Alison O'Neill, Douglas B. Jacoby, Abdellah Sentissi, Kamala Kesavan, Laura Sen
  • Publication number: 20130045163
    Abstract: The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.
    Type: Application
    Filed: May 23, 2012
    Publication date: February 21, 2013
    Applicant: MORPHOTEK, INC.
    Inventors: Alison O'Neill, Douglas B. Jacoby, Abdellah Sentissi, Kamala Kesavan, Laura Sen
  • Publication number: 20090304592
    Abstract: The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.
    Type: Application
    Filed: May 15, 2009
    Publication date: December 10, 2009
    Inventors: Alison O'Neill, Douglas B. Jacoby, Abdellah Sentissi, Kamala Kesavan, E. Michael Egan, Laura Sen